Olimpia Musumeci

6.2k total citations
110 papers, 2.8k citations indexed

About

Olimpia Musumeci is a scholar working on Rheumatology, Molecular Biology and Physiology. According to data from OpenAlex, Olimpia Musumeci has authored 110 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Rheumatology, 44 papers in Molecular Biology and 31 papers in Physiology. Recurrent topics in Olimpia Musumeci's work include Glycogen Storage Diseases and Myoclonus (41 papers), Lysosomal Storage Disorders Research (29 papers) and Mitochondrial Function and Pathology (22 papers). Olimpia Musumeci is often cited by papers focused on Glycogen Storage Diseases and Myoclonus (41 papers), Lysosomal Storage Disorders Research (29 papers) and Mitochondrial Function and Pathology (22 papers). Olimpia Musumeci collaborates with scholars based in Italy, United States and United Kingdom. Olimpia Musumeci's co-authors include António Toscano, Carmelo Rodolico, S. DiMauro, Sara Shanske, Emanuele Barca, Salvatore DiMauro, Giuseppe Vita, M. Aguennouz, Nereo Bresolin and Giacomo P. Comi and has published in prestigious journals such as PLoS ONE, Brain and Neurology.

In The Last Decade

Olimpia Musumeci

102 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olimpia Musumeci Italy 32 1.4k 805 788 438 389 110 2.8k
Marcus Deschauer Germany 31 1.8k 1.3× 665 0.8× 611 0.8× 477 1.1× 756 1.9× 139 3.0k
Hasan O. Akman United States 29 1.3k 1.0× 424 0.5× 694 0.9× 201 0.5× 399 1.0× 71 2.5k
Massimiliano Filosto Italy 30 1.6k 1.2× 501 0.6× 343 0.4× 544 1.2× 786 2.0× 140 2.7k
Chuanzhu Yan China 24 1.4k 1.0× 366 0.5× 257 0.3× 311 0.7× 407 1.0× 172 2.4k
Helen Michelakakis Greece 27 706 0.5× 1.3k 1.6× 330 0.4× 115 0.3× 227 0.6× 101 2.1k
Andrea Dardis Italy 30 719 0.5× 1.8k 2.3× 488 0.6× 140 0.3× 112 0.3× 98 2.6k
Paz Briones Spain 29 2.1k 1.5× 420 0.5× 215 0.3× 199 0.5× 896 2.3× 70 2.7k
Silvia Tortorelli United States 30 1.0k 0.8× 621 0.8× 364 0.5× 122 0.3× 1.1k 2.8× 70 2.3k
Andoni Echaniz‐Laguna France 34 1.7k 1.2× 500 0.6× 241 0.3× 937 2.1× 157 0.4× 138 3.6k
Costanza Lamperti Italy 27 2.3k 1.7× 386 0.5× 246 0.3× 307 0.7× 1.1k 2.8× 74 3.0k

Countries citing papers authored by Olimpia Musumeci

Since Specialization
Citations

This map shows the geographic impact of Olimpia Musumeci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olimpia Musumeci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olimpia Musumeci more than expected).

Fields of papers citing papers by Olimpia Musumeci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olimpia Musumeci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olimpia Musumeci. The network helps show where Olimpia Musumeci may publish in the future.

Co-authorship network of co-authors of Olimpia Musumeci

This figure shows the co-authorship network connecting the top 25 collaborators of Olimpia Musumeci. A scholar is included among the top collaborators of Olimpia Musumeci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olimpia Musumeci. Olimpia Musumeci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bertino, Salvatore, Agostino Tessitore, Francesca Granata, et al.. (2025). Cerebral foreign body reaction (CFBR) after endovascular treatments is a rare event to be aware of: case series and review of literature. Journal of Neurology. 272(3). 251–251.
2.
Musumeci, Olimpia, Anna Maria Pugliese, Ilaria Arena, et al.. (2025). Management of presymptomatic juvenile patients with late-onset Pompe disease (LOPD). Neuromuscular Disorders. 47. 105277–105277. 1 indexed citations
3.
Tessa, Alessandra, Melissa Barghigiani, Alba Migliorato, et al.. (2024). Pseudodominance in RFC1-Spectrum Disorder. The Cerebellum. 23(6). 2622–2628. 2 indexed citations
4.
Horton, Mike, Stephan Wenninger, Haris Babačić, et al.. (2024). Improving outcome measures in late onset Pompe disease: Modified Rasch‐Built Pompe‐Specific Activity scale. European Journal of Neurology. 31(12). e16397–e16397. 1 indexed citations
5.
Toscano, António, Olimpia Musumeci, Michele Sacchini, et al.. (2023). Safety outcomes and patients’ preferences for home-based intravenous enzyme replacement therapy (ERT) in pompe disease and mucopolysaccharidosis type I (MPS I) disorder: COVID-19 and beyond. Orphanet Journal of Rare Diseases. 18(1). 338–338. 2 indexed citations
6.
Løkken, Nicoline, Andrea Martinuzzi, Miguel A. Martı́n, et al.. (2022). Muscle MRI in McArdle Disease. Neurology. 99(15). e1664–e1675. 5 indexed citations
7.
Lucía, Alejandro, Andrea Martinuzzi, Gisela Nogales‐Gadea, et al.. (2021). Clinical practice guidelines for glycogen storage disease V & VII (McArdle disease and Tarui disease) from an international study group. Neuromuscular Disorders. 31(12). 1296–1310. 30 indexed citations
8.
Camerino, Giulia Maria, et al.. (2021). Statin-Induced Myopathy: Translational Studies from Preclinical to Clinical Evidence. International Journal of Molecular Sciences. 22(4). 2070–2070. 25 indexed citations
9.
Surace, Laura, Jean‐Marc Doisne, Pedro Escoll, et al.. (2020). Polarized mitochondria as guardians of NK cell fitness. Blood Advances. 5(1). 26–38. 43 indexed citations
10.
Ruggeri, Paolo, et al.. (2020). Ultrasound assessment of diaphragm function in patients with late-onset Pompe disease. Neurological Sciences. 41(8). 2175–2184. 22 indexed citations
11.
Mormina, Enricomaria, Olimpia Musumeci, Agostino Tessitore, et al.. (2020). Intracranial aneurysm management in patients with late-onset Pompe disease (LOPD). Neurological Sciences. 42(6). 2411–2419. 5 indexed citations
12.
Musumeci, Olimpia, Edoardo Ferlazzo, Carmelo Rodolico, et al.. (2020). A Family With a Complex Phenotype Caused by Two Different Rare Metabolic Disorders: GLUT1 and Very-Long-Chain Fatty Acid Dehydrogenase (VLCAD) Deficiencies. Frontiers in Neurology. 11. 514–514. 3 indexed citations
13.
Filosto, Massimiliano, Stefano Cotti Piccinelli, Costanza Lamperti, et al.. (2019). Muscle pain in mitochondrial diseases: a picture from the Italian network. Journal of Neurology. 266(4). 953–959. 6 indexed citations
14.
Vita, Gian Luca, Gian Luca Vita, Francesca Polito, et al.. (2018). Hippo signaling pathway is altered in Duchenne muscular dystrophy. PLoS ONE. 13(10). e0205514–e0205514. 33 indexed citations
15.
Musumeci, Olimpia, Silvia Marino, Francesca Granata, et al.. (2018). Central nervous system involvement in late‐onset Pompe disease: clues from neuroimaging and neuropsychological analysis. European Journal of Neurology. 26(3). 442–442. 35 indexed citations
16.
Camerino, Giulia Maria, Olimpia Musumeci, Elena Conte, et al.. (2017). Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study. Frontiers in Pharmacology. 8. 500–500. 30 indexed citations
17.
Savarese, Marco, Giuseppina Di Fruscio, Giorgio Tasca, et al.. (2015). Next generation sequencing on patients with LGMD and nonspecific myopathies: Findings associated with ANO5 mutations. Neuromuscular Disorders. 25(7). 533–541. 51 indexed citations
18.
Musumeci, Olimpia, Paolo Ruggeri, Federica Montagnese, Giuseppe Girbino, & António Toscano. (2015). Breathing Pattern and Central Ventilatory Drive in Late-Onset Pompe Disease. Journal of Neuromuscular Diseases. 2(s1). S49–S49. 1 indexed citations
19.
Barca, Emanuele, Olimpia Musumeci, Lorenzo Peverelli, et al.. (2014). Cerebellar Ataxia with CoQ10 Deficiency Due to a Novel Mutation in ADCK3 (P6.057). Neurology. 82(10_supplement). 1 indexed citations
20.
Arnoldi, Alessia, Claudia Crimella, Erika Tenderini, et al.. (2011). Clinical phenotype variability in patients with hereditary spastic paraplegia type 5 associated with CYP7B1 mutations. Clinical Genetics. 81(2). 150–157. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcus Deschauer Breakdown of academic impact, for papers by Hasan O. Akman Breakdown of academic impact, for papers by Massimiliano Filosto Breakdown of academic impact, for papers by Chuanzhu Yan Breakdown of academic impact, for papers by Helen Michelakakis Breakdown of academic impact, for papers by Andrea Dardis Breakdown of academic impact, for papers by Paz Briones Breakdown of academic impact, for papers by Silvia Tortorelli Breakdown of academic impact, for papers by Andoni Echaniz‐Laguna Breakdown of academic impact, for papers by Costanza Lamperti
Rankless by CCL
2026